Executive Director of Biotherapeutics

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured; where treatments are smarter and less invasive; and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.

Learn more at

Job Overview
Job Function:
Discovery & Pre‑Clinical/Clinical Development
Job Sub‑Function:
Biotherapeutics R&D
Job Category:
People Leader
Job Location s:
Cambridge, Massachusetts, United States;
Spring House, Pennsylvania, United States

• Strategic Leadership & Innovation:
  Define and articulate a competitive vision and strategy on function first Lead Design that aligns with the company's overall R&D goals and therapeutic area priorities. Identify and champion novel scientific approaches and technological advancements to enhance the speed, efficiency, and success rate of biologics design achieving desired pharmacology, with a strong focus on end‑to‑end concept leveraging both internal and external capabilities.
• Scientific Oversight & Execution:
  Provide rigorous scientific oversight and strategic direction to all biologics protein sciences and design teams while working closely with Therapeutic Area partners. Ensure consistent success and delivery of pipeline while pushing industry pace and standards.
• Technological Advancement & Disruption:
  Continuously evaluate and integrate state‑of‑the‑art technologies and methodologies that can significantly improve or disrupt current biologics discovery paradigms. Partner seamlessly with Insilico Discovery partners to evaluate, advance, and integrate next generation computational tools to improve speed and success in complex reagent and therapeutic design and disease biology relevant pharmacology.
• Talent Leadership & Development:
  Build, mentor, and develop a high‑performing team of scientists and leaders. Foster a culture of accountability, scientific excellence, collaboration, innovation, and continuous learning.
• Portfolio Management:
  Partner closely with Therapeutic Areas and Portfolio management team to prioritize discovery programs, research, and allocate resources effectively to build and deliver a robust and diverse pipeline of biologics.
• Competitive Landscape Awareness:
  Maintain a deep understanding of the competitive landscape, emerging trends, and potential disruptive technologies in the biologics discovery space.
• Collaboration & Communication:
  Foster strong collaborations in a matrixed organization, with internal research functions, translational science, development, and clinical teams. Effectively communicate research strategies, progress, and key findings to senior leadership, internal stakeholders, and external partners.
• Resource and Budget Management:
  Maximize and continuously optimize investment performance to ensure optimal operation and delivery on strategic objectives.
• External Representation:
  Represent the company externally at scientific conferences, in interactions with academic collaborators, and potential partners. Establish and invest in relevant external key opinion leader network to foster next‑generation technology and scientific discovery.

• Ph.D. in a relevant scientific discipline (e.g., Molecular Biology, Cell Biology, Immunology, Biochemistry, Bioengineering, Computational Biology).
• 15+ years of progressive leadership experience in biologics within the pharmaceutical or biotechnology industry, with a significant portion spent at a senior leadership level.
• Demonstrated track record of innovation:
  Proven history of driving innovation in biologics, evidenced by contributions to successful drug candidates, publications in high‑impact journals, patents, or the implementation of novel, impactful technologies and strategies.
• Expertise in complex biologics:
  In‑depth understanding and experience in the discovery and design of complex biologic modalities (e.g., multispecific antibodies, antibody‑drug conjugates, cell…